Trials / Unknown
UnknownNCT04099212
15% TOPICAL RESORCINOL FOR HURLEY I-II HIDRADENITIS SUPPURATIVA.
OBSERVATIONAL CASE-ONLY PROSPECTIVE STUDY OF EFFECTIVENESS AND SAFETY OF 15% TOPICAL RESORCINOL FOR ADULTS WITH HURLEY I-II HIDRADENITIS SUPPURATIVA.
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 40 (estimated)
- Sponsor
- Fundación Pública Andaluza para la gestión de la Investigación en Sevilla · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Prospective, observational cross-sectional study to evaluate the response of patients with HS I-II to monotherapy treatment of topical resorcin 15%, taking into account its safety, impact on quality of life and subclinical evolution.
Conditions
Timeline
- Start date
- 2019-05-15
- Primary completion
- 2020-04-30
- Completion
- 2020-08-30
- First posted
- 2019-09-23
- Last updated
- 2020-02-12
Locations
1 site across 1 country: Spain
Source: ClinicalTrials.gov record NCT04099212. Inclusion in this directory is not an endorsement.